ANRO

Alto Neuroscience, Inc.

HealthcareBiotechnologyUSUSDPeers →

$25.61

LiveJun 24, 2026

AI Brief

Market cap

$898.76M

52w range

2.15 – 28.44

P / E

—

EPS

—

Volume

28.87K

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Explain this page

Arphra AIPlain-English read on Alto Neuroscience, Inc.’s valuation

News pulse · 14d

2 stories—All news →

06-15today

Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia9d
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia9d
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights42d
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights42d

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for ANRO.

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $34.60 (+35.10%)

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
+6.59%	+8.62%	+15.17%	+22.08%	+24.31%	+37.30%	+922.59%	+18.07%	+18.07%	+18.07%	+18.07%

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Aftermarket

Live

Jun 24, 02:15 PM

Last trade

$25.61

133 sh

Bid

$25.61

100 sh

Ask

$25.86

100 sh

Spread

$0.250

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.01%
Consumer Cyclical
+0.94%
Energy
+0.84%
Consumer Defensive
+0.82%
Financial Services
+0.23%
Basic Materials
-0.11%
Healthcare
-0.18%
Communication Services
-0.18%
Industrials
-0.47%
Technology
-0.85%
Utilities
-1.03%

Top industries (issuer's industry highlighted)

Biotechnology
+2.13%
Travel Services
+10.21%
Medical - Healthcare Information Services
+4.48%
Residential Construction
+4.17%
Leisure
+3.63%
Gold
-3.20%
Discount Stores
+2.61%
Airlines, Airports & Air Services
+2.58%
Medical - Diagnostics & Research
+2.44%
Financial - Mortgages
+2.27%
Industrial Materials
-2.24%
Chemicals
-2.18%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Recent analyst activity

1 latest

Jun 17, 2026GradeBuy → BuyH.C. Wainwright Reiterates Buy Rating on Alto Neuroscience (ANRO)H.C. Wainwright

Peers

No peer list available for ANRO.

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin